Zeyad Alraddadi

Dr. Zeyad Alraddadi is an Associate Scientist and Consultant in Medical Molecular Genetics with extensive expertise spanning both clinical practice and biomedical research. His work integrates scientific excellence, innovation, and healthcare leadership to advance translational research in molecular genetics, public health, epidemiology, biomarker discovery, drug discovery, targeted therapeutics, and precision medicine. His research focuses on improving the prevention, diagnosis, and treatment of cancer, metabolic, infectious, and neurological diseases through innovative and patient-centered approaches.

Dr. Alraddadi combines a strong foundation in basic science with expertise in public health to develop novel therapeutic strategies and support evidence-based disease prevention. In addition to his research, he is actively engaged in strategic research leadership, education, and capacity building, contributing to the advancement of translational medicine and precision healthcare. He holds a PhD from University College London (UCL), a Postgraduate Diploma (PgDip) from the University of Manchester, an Associate Fellowship in Higher Education Teaching (UK), and a Master of Business Administration (MBA), reflecting his multidisciplinary approach to research, clinical practice, and academic leadership.

Medical Molecular Genetics

Biomarker Discovery

Drug Discovery

Public Health & Epidemiology

Biostatistics

Clinical Research

Precision Medicine

Research Leadership

Neurodegenerative Research

Dr. Zeyad Alraddadi has over 16 years of clinical laboratory and postdoctoral experience, specializing in molecular genetics, immunology, biochemistry, and public health within AABB-, JCI-, and CAP-accredited healthcare and research environments. He currently serves as an Associate Scientist and Consultant in Medical Molecular Genetics at King Faisal Specialist Hospital & Research Centre (KFSH&RC), while also holding an appointment as an Adjunct Assistant Professor at Alfaisal University.

Prior to his current role, Dr. Alraddadi served as Deputy Director of the Mawhiba Program, Acting Medical Laboratory Supervisor, CAP Inspector, and a key contributor to the strategic development of research infrastructure at KFSH&RC–Jeddah. He holds a PhD from University College London (UCL), a Postgraduate Diploma (PgDip) from the University of Manchester, and a Master of Business Administration (MBA). He is also certified in Training of Trainers (TOT) and is an Associate Fellow of the Higher Education Academy (UK), reflecting his commitment to education and academic excellence. His research has contributed to the development of innovative in silico drug discovery programs and advances in translational and precision medicine.